Net profit of Trident Texofab reported to Rs 0.70 crore in the quarter ended June 2024 as against net loss of Rs 0.13 crore during the previous quarter ended June 2023. Sales rose 11.30% to Rs 25.71 crore in the quarter ended June 2024 as against Rs 23.10 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales25.7123.10 11 OPM %5.956.19 - PBDT1.340.27 396 PBT0.93-0.14 LP NP0.70-0.13 LP Powered by Capital Market - Live News

Trident Texofab has revised the meeting of the Board of Directors which was scheduled to be held on 17 July 2024. The meeting will now be held on 18 July 2024.Powered by Capital Market - Live News

Trident Texofab will hold a meeting of the Board of Directors of the Company on 17 July 2024.Powered by Capital Market - Live News

Net loss of Trident Texofab reported to Rs 0.10 crore in the quarter ended March 2024 as against net profit of Rs 0.06 crore during the previous quarter ended March 2023. Sales rose 24.46% to Rs 30.17 crore in the quarter ended March 2024 as against Rs 24.24 crore during the previous quarter ended March 2023.For the full year,net profit declined 51.35% to Rs 1.08 crore in the year ended March 2024 as against Rs 2.22 crore during the previous year ended March 2023. Sales rose 3.24% to Rs 99.48 crore in the year ended March 2024 as against Rs 96.36 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales30.1724.24 24 99.4896.36 3 OPM %3.382.23 -6.196.55 - PBDT-0.070.34 PL 2.514.50 -44 PBT-0.48-0.07 -586 0.862.86 -70 NP-0.100.06 PL 1.082.22 -51 Powered by Capital Market - Live News

Trident Texofab has revised the meeting of the Board of Directors which was scheduled to be held on 21 May 2024. The meeting will now be held on 25 May 2024.Powered by Capital Market - Live News